Evaluation of indeterminate biliary strictures.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype.Frontiers in immunology · 2018
   Trial
2. Morpho-molecular approach (NGSPathologica · 2025
   Article
3. Deep Learning-Based Detection of Malignant Bile Duct Stenosis in Fluoroscopy Images of Endoscopic Retrograde Cholangiopancreatography.Digestion · 2025
   Article
4. An overview of extrahepatic cholangiocarcinoma: from here to where?Frontiers in oncology · 2023
   Review
5. Digital Cholangioscopic Interpretation: When North Meets the South.Digestive diseases and sciences · 2022
   Observational
6. Diagnosis of Malignant Biliary Stricture: More is Better.Clinical endoscopy · 2018
   Article

Corrections and comments

• Erratum for
  Evaluation of indeterminate biliary strictures.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract